Abstract: As a part of our systematic study of copper(II) complexes in presence of biologically active ligands, we concluded to realize experiments with methyl-or methoxysalicylatocopper(II) complexes in presence of 2-aminomethylpyridine (ampy) ligand. This has resulted in four new complexes of the formula Cu(XSal) 2 (ampy) (where XSal are 3-MeSal − = 3-methylsalicylate, 4-MeSal − = 4-methylsalicylate, 5-MeSal − = 5-methylsalicylate, or 4-MeOSal − = 4-methoxylsalicylate anions). The synthesis, elemental analysis and spectral properties (EPR, electronic and infrared) are reported. The Cu(II) atom in all four complexes is probably coordinated by two nitrogen atom of the bidentate chelating ampy as well as monodentate and/or highly asymmetrically chelating salicylate anions. Based on the analyses it was concluded that the structure of these new compounds could be similar to [Cu(HCOO) 2 (ampy)], or [Cu(CH 3 COO) 2 (ampy)] that are reported in the literature.
Introduction
The study of transition metal systems for the preparation of designed solids has gained momentum over the last few decades due to their potential applications in material science, as well as in medicine (Shukla 2011) . The history of copper containing drugs with positive effects to various (e.g. inflammatory, infectious) diseases is colourful and they have been known since ancient times. The modern bioinorganic chemistry of copper is nowadays spread out throughout a wide range of topics but the preparation of new copper complexes and study of their potential biological properties for medicine is one of the most frequent. The solid state properties of the prepared compounds are related to structural arrangement of individual molecular species and to their mutual nonbonding interactions that are frequently related to the type and/or position of different substituents of the used ligand molecules and ions. Copper(II) complexes of anti-inflammatory drugs have been found to be more potent than the parent ligand (Sorenson 1976) . It was found that copper complexes of salicylic acid and 3-methoxysalicylic acid can act as superoxide dismutase mimetics (O'Connor 2012). Salicylic acid and some its derivatives are known as nonsteroidal anti-inflammatory drugs. The ligand 2-aminomethylpyridine (known also as picolylamine) can act as a chelating as well as a bridging ligand (Shukla 2011) . Generally speaking, the copper complexes with 2-aminomethylpyridine (ampy) are known for their mainly chelating manner of coordination and the bridging mode of bonding to central atoms is rather rare. The latter coordination mode was mostly found in a few Ag(I) complexes (Yilmaz 2010 , Sailaja 2000 , Swarnabala, 1997 , Bowmaker, 2005 , Feazell 2005 and in some rhodium complex (Crawford 1994) . Moreover, the central atom oxidation state, the type and number of the other donor atoms, as well as their relative positions within the ligand Fig. 1 . The formulae of salicylic acid derivatives, 2-aminomethylpyridine and 2-hydroxymethylpyridine.
are the major factors determining the individual complex molecule activity including its activity in biological environment (Ali 2013) . In relation to that our interest is targeted to systematic study of the prepared salicylatocopper complexes with different N-donor ligands that could model different biological function including the antioxidant properties. As the extension of our previous study of the salicylatocopper(II) complexes with 2-hydroxymethylpyridine (2-hydroxymethylpyridine known also as 2-pyridylcarbinol and abbreviated here as hmpy) we are in present paper focusing our attention on the investigation of the relation between the preparation, composition and structure of copper(II) complexes with different methyl-, or methoxysalicylic acid derivatives in presence of the ampy ligand and to the further comparison of the complexes containing pyridine derivatives containing the sidearm with -NH 2 or -OH group. We present here four new complexes, of general formula [Cu(XSal) 2 (ampy)] (where XSal = 3-, 4-or 5-methylsalicylate anion or 4-methoxylsalicylate anion) together with their spectral properties and proposed structure.
Experimental
Synthesis of complexes 2-Aminomethylpyridine (1mmol or 0.5 mmol) was added to water solution of copper(II) acetate (0.5 mmol) under stirring. Methyl-or methoxysalicylic acid (1mmol) was added to reaction mixture together with necessary amount of solvent (ethanol, methanol, acetonitrile or water). The reaction mixture was stirred for a few hours at room temperature. The precipitates were filtered off, washed with small amount of appropriate solvent and dried in air at ambient temperature. The clear mother liquid solutions were left to crystallize at laboratory temperature. The all samples were characterized by all available spectral methods (electronic and infrared spectroscopy, elemental analysis, EPR spectroscopy). Anal Calc for Cu(3-MeSal) 2 (ampy): C, 55.8; H, 4.7; N,5.9. Found: C, 55.4; H, 4.7; N, 6.2. Anal Calc for Cu(4-MeSal) 2 (ampy): C, 55.8; H, 4.7; N,5.9. Found: C, 56.7; H, 4.7; N, 4.8.
Anal Calc for Cu(5-MeSal) 2 (ampy): C, 55.8; H, 4.7; N, 5.9. Found: C, 55.8; H, 4.6; N, 5.7 . Anal Calc for Cu(4-MeOSal) 2 (ampy): C, 52.2; H, 4.4; N,5.5. Found: C, 52.8; H, 4.4; N, 5.0.
Apparatus and equipment
Analytical grade (Aldrich, or Sigma) chemicals were used without further purification. Carbon, hydrogen and nitrogen analyses were carried out on a CHNSO FlashEA TM 1112 Automatic Elemental Analyzer. The infrared spectra (4000-400 cm -1 ) were measured with a NICOLET 5700 FT-IR (Nicolet) spectrophotometer at room temperature using ATR technique. The electronic spectra (190-1100 nm) of the complexes were measured in nujol suspension with a SPECORD 250 Plus (Carl Zeiss Jena) spectrophotometer at room temperature. EPR spectra of the polycrystalline samples were measured with a X-band EPR spectrometer (EMX series, Bruker) at room temperature.
Results and discussion
The four blue products of unexpected composition were obtained despite the modification of reaction conditions e.g. variation of Cu : ampy molar ratio and/or changing the used solvent in a contrary to the results found for acetate and formate products (Barquín 2009) where up to the three different molar ratios Cu : ampy were observed. All complexes under study were characterized by the infrared and electronic spectra. The obtained spectral data show that the composition of the prepared complexes is not affected by changing the reaction conditions. The carboxylate stretching frequencies n as (COO -) and n s (COO -) for all complexes under study are at about 1625 and 1435 cm -1 , respectively. Individual data are given in Table 1 . Differences between antisymmetric and symmetric stretches (∆n = n as -n s ) are for all prepared complexes greater than ∆n for the ionic form of the appropriate acid, which is consistent with the monodentate and/or highly asymmetric bidentate bonding mode of carboxylate group (Nakamoto 2009 . The shades of blue colour for complexes (1)-(4) are in good agreement with the electronic spectra that are represented by broad asymmetric complex but unresolved bands with a maximum at about 630 nm. The complexity of the electronic spectra is another result that points out that the central atoms coordination polyhedra in all products probably are less symmetrical than one can expect for the given number of donor atoms. There are also intraligand charge transfer bands (215-300 nm) and LMCT band in the range of 300-350 nm.
The EPR spectra (Figs. 2 and 3 ) of powder samples were measured at room temperature. The spectra of mentioned samples are very similar to each other with partly resolved axial symmetry features. The simulation of spectra gave us the g-factor values (Table 2) in the range of 2.07-2.10 for g ┴ and 2.11-2.24 for g || , respectively. The "pseudoaxial" character with g ┴ and g || values close each to other resulted in G parameters within the narrow range from 1,15 to 2,67 (see Tab 2) and indicate the presence of some exchange coupling between copper(II) atoms having the coordination spheres of distorted tetragonal symmetry that result in d x 2 -y 2 ground states (Hathway 1970 Finally, the obtained data allow us to suggest that the stoichiometrically unusual complexes of composition Cu(XSal) 2 (ampy) probably contain the ampy chelating ligand together with the asymmetrically bonded salicylato anions thus giving {CuN 2 O 2 O'O"} chromophores, but that could be proved by solving the structure of individual obtained products, which was up to now unsuccessful. Searching through the Cambridge Crystallographic Database gives some hints. In about a half of all structures (38) of copper(II) complexes containing the ampy ligand moiety the Cu : ampy molar ratio is 1 : 2, and there are two "extreme" ratios -one example of 1 : 3 ratio and the other one exhibits 2 : 1 stoichiometry. Remaining 16 examples are of 1 : 1 stoichiometry, but only 9 of them are truly 1 : 1 and the rest of them are of 1 : 1 as a consequence of some other reasons, e.g. presence of chelating multidentate ligand, or presence of bridging anionic ligand(s). As it was mentioned above in two compounds there are carboxylato anions present together with the ampy ligand -Cu(RCOO) 2 (ampy), where R = H, or CH 3 (Barquín 2009). Despite of similarity of the acetate and formate anions the structures are different (Fig 4 and 5) . While formate complex exhibit chain structure (Fig. 4) , the acetate one is of molecular structure (distance between the O2 atom and the neighbouring Cu1 is close to 3 Å). 
